US Patent Issued to PHEON THERAPEUTICS on March 24 for "Anti-liferative agents comprising substituted benzo[epyrido[1,2-a[1,4diazepines" (British Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,857, issued on March 24, was assigned to PHEON THERAPEUTICS LTD (Hertfordshire, Great Britain).

"Anti-liferative agents comprising substituted benzo[epyrido[1,2-a[1,4diazepines" was invented by Paul Joseph Mark Jackson (Hertfordshire, Great Britain), David Edwin Thurston (Hertfordshire, Great Britain) and Khondaker Mirazur Rahman (Hertfordshire, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to substituted pyrridinobenzodiazepines (PDDs) of formula (XVI) and pharmaceutically acceptable salts thereof, which are useful as medicaments, in particular as anti-proliferative agents."

The patent was filed on Dec. 21, 20...